Karus Therapeutics Appoints Scientific Advisory Board

News   Apr 09, 2013

 
Karus Therapeutics Appoints Scientific Advisory Board
 
 
 

RELATED ARTICLES

Metabolomic Profiling Identifies Taurine as New MS Therapeutic

News

New research suggests that administering taurine, a molecule naturally produced by human cells, could boost the effectiveness of current multiple sclerosis (MS) therapies. The discovery also highlights the potential for a technique called “metabolomic profiling,” which can identify useful endogenous metabolites the body already makes in small quantities, such as taurine, for new applications in drug therapies.

READ MORE

Chemists Have Synthesized New Isoquinoline Derivatives

News

Chemists have synthesized new isoquinoline derivatives. Due to their biological activity, these compounds may be applicable in new drugs, from antispasmodics to bactericidal agents. In addition, in the future they may show effectiveness in the treatment of Alzheimer's disease.

READ MORE

Malvern Panalytical Wins Innovate UK Grant

News

Funding for 3-year-long project to lead biopharmaceutical consortium on aggregation analytics.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE